Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis (Record no. 15858)

MARC details
000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211231102145.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211231b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 15272
Author Kawthar, F. Nassir
245 ## - TITLE STATEMENT
Title Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis
250 ## - EDITION STATEMENT
Volume, Issue number Vol.53(5), Sep-Oct
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mumbai
Name of publisher, distributor, etc. Wolter Kluwer
Year 2021
300 ## - PHYSICAL DESCRIPTION
Pagination 364-370p.
520 ## - SUMMARY, ETC.
Summary, etc. OBJECTIVES: The purpose of this research was to determine the effectiveness of Pentaglobin®<br/>as adjuvant therapy in the treatment of sepsis in preterm newborns.<br/>MATERIALS AND METHODS: It was a prospective, observational, randomized study for 272<br/>premature neonates and very low birth weight (VLBW) that were diagnosed with sepsis carried at<br/>neonatal intensive care units. The patients randomized into control group who received standard<br/>sepsis antibiotic treatments, and an intervention group who received Pentaglobin® 5 ml/kg daily for<br/>3 consecutive days as an adjunct therapy to a standard sepsis antibiotic treatment.<br/>RESULTS: Multiple organisms that isolated from culture specimens were Gram‑negative bacteria,<br/>Gram‑positive, and candida (56.25%, 42.28%, and 1.47%, respectively). The disease duration was<br/>distinctively longer in patients who were treated by the standard antibiotic protocol (mean ± standard<br/>deviation [SD]: 30.76 ± 3.97, odds ratio [OR]: 30.76, 95% confidence interval [CI]: 30.051, 31.473)<br/>comparing to the patients who received Pentaglobin adjuvant therapy (mean ± SD: 26.48 ± 5.55,<br/>OR: 26.48, 95% CI: 25.489, 27.477) (P < 0.000). Patients treated by standard antibiotic protocol<br/>were associated to a substantially increased risk of death (11.76%, hazard ratio 4.400, 95% CI:<br/>1.432, 13.529, P = 0.009).<br/>CONCLUSION: Neonatal sepsis is more common in premature and VLBW newborns, and<br/>Pentaglobin® management of newborn nosocomial sepsis might be used in addition to other therapies
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4774
Topical term or geographic name entry element PHARMACOLOGY
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 15273
Co-Author AL-Saddi, Yasir Ibrahim
773 0# - HOST ITEM ENTRY
Title Indian Journal of Pharmacology
Place, publisher, and date of publication Andheri - Mumbai Wolters Kluwer India Private Limited
International Standard Serial Number 0253-7613
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.ijp-online.com/temp/IndianJPharmacol535364-171952_044635.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
    Dewey Decimal Classification     School of Pharmacy School of Pharmacy Archieval Section 31/12/2021   2021-2022675 31/12/2021 31/12/2021 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.